Allena Pharmaceuticals

Allena Pharmaceuticals is focused on treating complex metabolic conditions that can lead to significant and costly health complications. The company aims to reduce the burden of toxic metabolites such as oxalate and uric acid. These metabolites are normal byproducts of cellular activity and are also derived from the typical diet. In certain circumstances, they can build up and lead to complications such as hyperoxaluria and kidney stones (nephrolithiasis) in the case of oxalate, or hyperuricemia and gout in the case of uric acid.

Company Growth (employees)
Type
Private
HQ
Newton, US
Size (employees)
32 (est)
Allena Pharmaceuticals is headquartered in Newton, US

Key People at Allena Pharmaceuticals

Alexey Margolin

Alexey Margolin

President and Chief Executive Officer
Hugh Wight

Hugh Wight

Vice President of Technical Operations

Allena Pharmaceuticals Office Locations

Allena Pharmaceuticals has an office in Newton
Newton, US (HQ)
One Newton Executive Park, Suite 202

Allena Pharmaceuticals Metrics

Summary Metrics

Allena Pharmaceuticals's latest funding round in December 2015 was reported to be $53 m. In total, Allena Pharmaceuticals has raised $93 m

Allena Pharmaceuticals Company Life

You may also be interested in